openPR Logo
Press release

US$ 18.1 Billion Statin Market Research Report 2023-2028

03-14-2023 12:59 PM CET | Health & Medicine

Press release from: IMARC Group

Statin Market

Statin Market

According to the latest report by IMARC Group, titled "Statin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028," the global statin market size reached US$ 14.9 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 18.1 Billion by 2028, exhibiting a growth rate (CAGR) of 3.2% during 2023-2028. Statin is a lipid-lowering medication that is consumed by patients to reduce their blood cholesterol levels. It works by inhibiting an enzyme, HMG-CoA reductase, that plays a major role in the production of cholesterol in the liver. By reducing the level of cholesterol produced by the liver, statins help to lower total cholesterol and low-density lipoprotein (LDL) cholesterol levels in the bloodstream. As a result, it aids in preventing instances of atherosclerosis and heart attacks and has significant anti-inflammatory and plaque-stabilizing effects. It also helps in minimizing vascular inflammation and oxidative stress in the body. Some commonly available statins include atorvastatin, rosuvastatin, lovastatin, and simvastatin.

Request for a free sample copy of this report: https://www.imarcgroup.com/statin-market/requestsample

Statin Market Growth:

The increasing prevalence of hypercholesterolemia is driving the global market. Along with this, the wide utilization of statin for the treatment of cardiovascular diseases as it assists in reducing the risks of heart attacks and stroke among individuals is catalyzing the market. Moreover, the rising consumer preference for over-the-counter (OTC) drugs, which are generally more affordable than brand-name drugs is fuelling the demand. The market is further driven by the growing adoption of combination therapies that use statins along with other cholesterol-reducing compounds, such as ezetimibe. With continual advancements in genetic testing and personalized medicine, statins are increasingly being tailored to individual patients based on their genetic profiles and other risk factors, this, in turn, is creating a positive market outlook.

Ask Analyst for Instant Discount and Download Full Report with TOC & List of Figure: https://www.imarcgroup.com/statin-market

Competitive Landscape With Key Players :

• Abbott Laboratories
• AstraZeneca
• Aurobindo Pharma
• Biocon
• GlaxoSmithKline
• Merck & Co.
• Novartis
• Pfizer

Key Market Segmentation:

Breakup by Type:

• Synthetic Statins
• Natural Statins

Breakup by Therapeutic Area:

• Cardiovascular Disorders
• Obesity
• Inflammatory Disorders
• Others

Breakup by Drug Class:

• Atorvastatin
• Fluvastatin
• Lovastatin
• Pravastatin
• Simvastatin
• Others

Breakup by Application:

• Dyslipidemia
• Others

Breakup by Distribution:

• Hospitals
• Clinics
• Others

Breakup by Region:

• North America
• Asia Pacific
• Europe
• Latin America
• Middle East and Africa

Key highlights of the report:

• Market Performance
• Market Outlook
• Porter's Five Forces Analysis
• Market Drivers and Success Factors
• SWOT Analysis
• Value Chain
• Comprehensive Mapping of the Competitive Landscape

Note: If you need specific information that is not currently within the scope of the report, we can provide it to you as a part of the customization.

Other Reports of IMARC Group:

https://www.digitaljournal.com/pr/news/interior-design-industry-growth-in-india-cagr-of-7-40-research-report-2022-2027
https://www.digitaljournal.com/pr/news/healthcare-biometrics-market-growth-industry-demand-top-companies-analysis-business-opportunity-and-research-report-2022-2027
https://www.digitaljournal.com/pr/news/beauty-and-personal-care-products-industry-trends-growth-analysis-overview-and-forecast-report-2023-2028
https://www.digitaljournal.com/pr/news/e-kyc-market-size-top-companies-overview-growth-rate-cagr-of-21-9-research-report-2023-2028
https://www.digitaljournal.com/pr/news/microinsurance-market-analysis-report-2023-2028-industry-share-growth-overview-and-forecast
https://www.digitaljournal.com/pr/news/saudi-arabia-luxury-market-analysis-report-2023-2028-cagr-of-11-6-

Contact Us:

IMARC Group
134 N 4th St. Brooklyn, NY 11249, USA
Email: Sales@imarcgroup.com
Tel No:(D) +91 120 433 0800
Americas:- +1 631 791 1145 | Africa and Europe :- +44-702-409-7331 | Asia: +91-120-433-0800, +91-120-433-0800

About Us:

IMARC Group is a leading market research company that offers management strategy and market research worldwide. We partner with clients in all sectors and regions to identify their highest-value opportunities, address their most critical challenges, and transform their businesses.

IMARC's information products include major market, scientific, economic and technological developments for business leaders in pharmaceutical, industrial, and high technology organizations. Market forecasts and industry analysis for biotechnology, advanced materials, pharmaceuticals, food and beverage, travel and tourism, nanotechnology and novel processing methods are at the top of the company's expertise.

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release US$ 18.1 Billion Statin Market Research Report 2023-2028 here

News-ID: 2974427 • Views:

More Releases from IMARC Group

Burnt Lime Production Cost Report 2025: Plant Setup Economics and Financial Outlook
Burnt Lime Production Cost Report 2025: Plant Setup Economics and Financial Outl …
Burnt lime, also known as quicklime or calcium oxide (CaO), is a widely used chemical compound produced by the thermal decomposition of limestone in a kiln at high temperatures. It appears as a white, caustic, and crystalline solid with strong alkaline properties. Burnt lime serves as a critical raw material in industries such as construction, steel, paper, sugar, water treatment, and chemical manufacturing due to its reactivity and versatility. Setting up
Report on Glucose Powder Manufacturing Plant 2025: Cost Breakdown, CapEx, OpEx, and Business Plan
Report on Glucose Powder Manufacturing Plant 2025: Cost Breakdown, CapEx, OpEx, …
Glucose powder is a fine, crystalline form of dextrose derived primarily from starch sources such as corn or wheat. It is widely used in the food and beverage industry as a sweetener, energy booster, and fermentation aid, while also finding applications in pharmaceuticals and medical formulations due to its rapid energy-releasing properties. Its versatility, quick solubility, and nutritional benefits make it a valuable ingredient across multiple industries. Setting up a glucose
Yeast Manufacturing Plant Setup Cost Report 2025: Feasibility Study and Profit Margins
Yeast Manufacturing Plant Setup Cost Report 2025: Feasibility Study and Profit M …
Yeast is a single-celled microorganism belonging to the fungi kingdom, widely used in food, beverage, and biotechnology industries. It plays a critical role in fermentation, converting sugars into alcohol and carbon dioxide, which makes it essential in baking, brewing, and winemaking. Beyond food applications, yeast is also utilized in bioethanol production, probiotics, and biopharmaceuticals, highlighting its industrial importance and versatility. Setting up a yeast manufacturing plant requires careful consideration of raw
Biofertilizer Production Plant Cost Analysis Report 2025: CapEx, OpEx, and ROI Evaluation for Plant Setup
Biofertilizer Production Plant Cost Analysis Report 2025: CapEx, OpEx, and ROI E …
Biofertilizer is an eco-friendly, organic product containing living microorganisms that enhance soil fertility and promote plant growth. It is widely used in sustainable agriculture, organic farming, and soil health improvement programs. Biofertilizers include nitrogen-fixing bacteria, phosphate-solubilizing bacteria, and potassium-mobilizing microorganisms that provide essential nutrients to plants naturally. Due to their environmentally friendly properties, biofertilizers serve as a critical component in various agricultural applications, including crop production, soil restoration, and sustainable

All 5 Releases


More Releases for Statin

Statin Market Size Set for Steady Growth Amid Rising Cardiovascular Health Conce …
Statin Market Poised for Steady Growth Amid Rising Cardiovascular Concerns The statin market is experiencing consistent growth, driven by the increasing prevalence of cardiovascular diseases (CVDs) and heightened awareness about cholesterol management. This press release delves into the market's current valuation, growth drivers, opportunities, recent trends in the U.S. market, key market segments, competitive landscape, and regional dynamics in major countries. Request Sample Link For More Details: https://www.maximizemarketresearch.com/request-sample/77560/ Market
Statin Market is Anticipated to Hit USD 18.93 Billion by 2030
The 𝐒𝐭𝐚𝐭𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 was valued USD 15.39 Bn in 2023 and is expected to reach USD 18.93 Bn by 2030, at a CAGR of 3% during a forecast period. 𝐒𝐭𝐚𝐭𝐢𝐧 𝐌𝐚𝐫𝐤𝐞𝐭 𝐎𝐯𝐞𝐫𝐯𝐢𝐞𝐰: Statins are widely used for the prevention and treatment of atherosclerosis, a condition that can lead to chest pain, heart attacks, and strokes. These medications primarily function by lowering low-density lipoprotein (LDL) cholesterol levels in the body, making them essential
Statin Market Expecting Huge Demand in Upcoming Years |Amgen, Biocon, AstraZenec …
Statin Market is the latest research study released by USD Analytics Market evaluating the market, size, share, sales, highlighting opportunities, risk analysis, and leveraging with strategic and tactical decision-making support. The factors that impact growth and rules concerning the use of information, the accessibility of dependable products in the market, and the enhancement of operational efficiency among players in Statin. Information on market development, trends, capabilities, technologies, and the shifting
Statin Market is forecasted to expand to USD 18.93 Billion by 2030
Anticipated Growth in Revenue: Statin Market was valued USD 15.39 Bn in 2023 and is expected to reach USD 18.93 Bn by 2030, at a CAGR of 3% during a forecast period. Statin Market Overview: The statin market encompasses pharmaceutical drugs primarily used to lower cholesterol levels in patients at risk of cardiovascular diseases. Statins work by inhibiting the enzyme HMG-CoA reductase, which plays a key role in cholesterol synthesis in the liver.
Statin Market Share, Trends, Key Drivers, Demand, Opportunities,Technologies and …
The statin market, projected to reach USD 22.21 billion by 2030 with a CAGR of 4.70% during 2023-2030, is driven by increasing cholesterol incidence due to lifestyle changes. Statins, pharmaceutical drugs prescribed to reduce cholesterol levels, are witnessing high demand globally due to urbanization and rising awareness about cholesterol-related disorders. Market Overview: • The market is driven by increasing cholesterol-related disorders due to lifestyle changes and advanced healthcare facilities. • Common statins include Atorvastatin, Lovastatin,
Statin Market To Cross US$ 20.0 Billion by 2032
According to latest report by IMARC Group, titled "Statin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2024-2032," The global statin market size reached US$ 15.4 Billion in 2023. Looking forward, IMARC Group expects the market to reach US$ 20.0 Billion by 2032, exhibiting a growth rate (CAGR) of 2.9% during 2024-2032. Global Statin Market Trends and Growth: The global statin market is majorly driven by the rising prevalence of